Drug & intervention
larotrectinib
RxCUI 2105628
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
2 shownNeoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.NCT06563999 · 2024-11-01
RECRUITINGTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060 · 2015-08-17
ACTIVE_NOT_RECRUITINGConditions being studied
Advanced Lymphoma1Advanced Malignant Solid Neoplasm1Bladder Carcinoma1Breast Carcinoma1Cervical Carcinoma1Colon Carcinoma1Colorectal Carcinoma1Endometrial Carcinoma1Esophageal Carcinoma1Exocrine Pancreas Carcinoma1Gastric Carcinoma1Glioma1Head and Neck Carcinoma1Hematopoietic and Lymphoid Cell Neoplasm1Kidney Carcinoma1Liver Carcinoma1Lung Cancer Stage III1Lung Carcinoma1Lymphoma1Malignant Uterine Corpus Neoplasm1
Research locations
AlbuquerqueNew Mexico, United States1AllentownPennsylvania, United States1AnaheimCalifornia, United States1Ann ArborMichigan, United States1AshevilleNorth Carolina, United States1AtlantaGeorgia, United States1AugustaGeorgia, United States1AuroraColorado, United States1AustinTexas, United States1AventuraFlorida, United States1BakersfieldCalifornia, United States1BaltimoreMaryland, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.